Arrowhead Pharmaceuticals
ARWR
#1956
Rank
โ‚ฌ8.47 B
Marketcap
61,26ย โ‚ฌ
Share price
4.41%
Change (1 day)
169.77%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -1,12ย โ‚ฌ

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,06ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -4,26ย โ‚ฌ a decrease over its 2023 EPS that were of -1,63ย โ‚ฌ.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-1,12ย โ‚ฌ-73.69%
2024-4,26ย โ‚ฌ161.39%
2023-1,63ย โ‚ฌ17.36%
2022-1,39ย โ‚ฌ19.85%
2021-1,16ย โ‚ฌ61.9%
2020-0,72ย โ‚ฌ-216.67%
20190,61ย โ‚ฌ-210.77%
2018-0,55ย โ‚ฌ38.3%
2017-0,40ย โ‚ฌ-64.93%
2016-1,14ย โ‚ฌ-16.25%
2015-1,36ย โ‚ฌ28%
2014-1,06ย โ‚ฌ-3.85%
2013-1,11ย โ‚ฌ-31.58%
2012-1,62ย โ‚ฌ331.82%
2011-0,37ย โ‚ฌ-51.11%
2010-0,77ย โ‚ฌ-79.07%
2009-3,66ย โ‚ฌ-37.68%
2008-5,88ย โ‚ฌ-16.87%
2007-7,07ย โ‚ฌ38.33%
2006-5,11ย โ‚ฌ122.22%
2005-2,30ย โ‚ฌ42.11%
2004-1,62ย โ‚ฌ533.33%
2003-0,26ย โ‚ฌ-99.08%
2002-27,66ย โ‚ฌ25%
2001-22,13ย โ‚ฌ33.33%
2000-16,60ย โ‚ฌ-120.22%
199982,08ย โ‚ฌ-400%
1998-27,36ย โ‚ฌ-81.48%
1997-147,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Alnylam Pharmaceuticals
ALNY
0,07668ย โ‚ฌ-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
2,04ย โ‚ฌ-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-2,45ย โ‚ฌ 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,89ย โ‚ฌ-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-6,88ย โ‚ฌ 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA